BioXcell功能性抗体系列推荐-InVivoMAb anti-human PD-1 (CD279)
浏览次数:52 发布日期:2025-9-22
来源:本站 仅供参考,谢绝转载,否则责任自负
产品信息:
|
- 纯度: >95%
- 内毒素:< 2EU/mg
- Clone: J116
|
 |
应用类型:
in vitro PD-1 neutralization
in vivo PD-1 blockade in humanized mice
参考文献:
1、"Programmed death-1 controls T cell survival by regulating oxidative metabolism" J Immunol 194(12): 5789-5800
2、"The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies" Gene Ther 22(2): 209-215.
3、"Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells" J Clin Invest 123(4): 1677-1693.
4、Singh, A., et al. (2012). "Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells" PLoS One 7(9): e44728.
5、"Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals" Clin Exp Immunol 157(1): 90-97.
6、"Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis" J Immunol 181(1): 116-125.